Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium.
Giorgio SeanoHadi T NiaKyrre E EmblemMeenal DattaJun RenShanmugarajan KrishnanJonas KloepperMarco C PinhoWilliam W HoMitrajit GhoshVasileios AskoxylakisGino B FerraroLars RiedemannElizabeth R GerstnerTracy T BatchelorPatrick Y WenNancy U LinAlan J GrodzinskyDai FukumuraPeigen HuangJames W BaishTimothy P PaderaLance L MunnRakesh K JainPublished in: Nature biomedical engineering (2019)
The compression of brain tissue by a tumour mass is believed to be a major cause of the clinical symptoms seen in patients with brain cancer. However, the biological consequences of these physical stresses on brain tissue are unknown. Here, via imaging studies in patients and by using mouse models of human brain tumours, we show that a subgroup of primary and metastatic brain tumours, classified as nodular on the basis of their growth pattern, exert solid stress on the surrounding brain tissue, causing a decrease in local vascular perfusion as well as neuronal death and impaired function. We demonstrate a causal link between solid stress and neurological dysfunction by applying and removing cerebral compression, which respectively mimic the mechanics of tumour growth and of surgical resection. We also show that, in mice, treatment with lithium reduces solid-stress-induced neuronal death and improves motor coordination. Our findings indicate that brain-tumour-generated solid stress impairs neurological function in patients, and that lithium as a therapeutic intervention could counter these effects.
Keyphrases
- cerebral ischemia
- resting state
- stress induced
- white matter
- functional connectivity
- subarachnoid hemorrhage
- brain injury
- randomized controlled trial
- squamous cell carcinoma
- high resolution
- physical activity
- multiple sclerosis
- computed tomography
- type diabetes
- photodynamic therapy
- clinical trial
- skeletal muscle
- young adults
- newly diagnosed
- end stage renal disease
- sleep quality
- insulin resistance
- papillary thyroid
- patient reported
- childhood cancer